Archive - February 2020
FDA Approves Audenz (Influenza A (H5N1) Monovalent Vaccine, Adjuvanted) as First-Ever Adjuvanted, Cell-Based Pandemic Influenza A (H5N1) Vaccine
Givlaari, Rybelsus lead crowded CHMP recommendations
GSK and Gilead join global efforts to tackle novel coronavirus
Rinvoq NICE approval could benefit 54,000 people
EMA accepts GSK’s belantamab mafodotin application
Pharmacists voice concerns over Brexit medicine supplies
Could ‘tailor-made’ vaccines halve bacterial disease rates?
Aimmune’s Palforzia is first peanut allergy drug cleared in US